C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
ALLG Equity

ALLG

OTCMKTS · ALLG

$1.91
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
43/100 composite
Fundamentals46
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

Allego receives a Neutral rating with a composite score of 42.8, placing it in the middle range of expectations. With a conviction level of 2 out of 5, Allego demonstrates balanced strengths and challenges. The fundamentals pillar is noteworthy for its alignment, despite reporting reduced revenue growth and negative operating margins, indicating structural profitability issues. Regulatory stability contributes positively, albeit with some areas lacking momentum. The market pillar lags due to insufficient available performance data and editorial presence remains minimal, as no significant company coverage or briefings have materialized recently.

Despite robust market capitalization positioning, the company suffers from a significant drop in year-over-year revenue and poor gross margins, leading to a notable net income deficit. Allego's negative EBITDA further highlights operational inefficiencies. Regulatory insight shows a lack of significant jurisdictional events and filing cadence irregularities. However, enforcement metrics exhibit resilience, with no infractions impacting the company adversely. The overall financial condition of Allego is stretched, with cash conservation efforts evident but balanced against ongoing high cash burn.

Moving forward, Allego's most viable pathway for enhancement within the Neutral band lies with strengthening its regulatory footing. The absence of recent jurisdictional events alongside sound enforcement practices indicates a solid foundation ripe for development. By increasing transparency and improving filing cadence, Allego could potentially leverage its regulatory environment to drive a stabilization of fundamentals, providing a clearer runway for steady growth amid operational and market challenges.

Scored: 2026-08-25Valid through: 2026-10-09Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
CEO
Mathieu Bonnet
CFO
Steven Salo
SEC CIK
0001874474
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$496.9M
Enterprise value
$939.6M
Price to book
10.94
Price to sales
3.42
EV / EBITDA
-6.62
Revenue (TTM)
$145.5M
Gross profit (TTM)
$25.2M
EBITDA
$-43.1M
Operating margin
-25.1%
Profit margin
-75.6%
Rev growth YoY
-20.1%
Return on equity
-760.3%
Return on assets
-8.7%
EPS (TTM)
$-0.46
Wall St. target price
$7.50
Shares outstanding
273.0M
Insider ownership
4.9%
Institutional ownership
95.6%
Beta
0.76
Full-time employees
190
GICS sector
Consumer Cyclical
GICS industry
Specialty Retail
Filings & DisclosuresPrimary sources
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for ALLG (ALLG)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for ALLG (ALLG), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for ALLG are maintained by Cannabis Investor News and refreshed throughout the trading day.